These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20530707)

  • 1. Controversies surrounding the use of etomidate for rapid sequence intubation in patients with suspected sepsis.
    Edwin SB; Walker PL
    Ann Pharmacother; 2010; 44(7-8):1307-13. PubMed ID: 20530707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should etomidate be used for rapid-sequence intubation induction in critically ill septic patients?
    Fengler BT
    Am J Emerg Med; 2008 Feb; 26(2):229-32. PubMed ID: 18272107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective observational study of the effect of etomidate on septic patient mortality and length of stay.
    Tekwani KL; Watts HF; Rzechula KH; Sweis RT; Kulstad EB
    Acad Emerg Med; 2009 Jan; 16(1):11-4. PubMed ID: 19055676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients.
    Cotton BA; Guillamondegui OD; Fleming SB; Carpenter RO; Patel SH; Morris JA; Arbogast PG
    Arch Surg; 2008 Jan; 143(1):62-7; discussion 67. PubMed ID: 18209154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages and disadvantages of etomidate use for intubation of patients with sepsis.
    Cherfan AJ; Arabi YM; Al-Dorzi HM; Kenny LP
    Pharmacotherapy; 2012 May; 32(5):475-82. PubMed ID: 22488264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial.
    Jabre P; Combes X; Lapostolle F; Dhaouadi M; Ricard-Hibon A; Vivien B; Bertrand L; Beltramini A; Gamand P; Albizzati S; Perdrizet D; Lebail G; Chollet-Xemard C; Maxime V; Brun-Buisson C; Lefrant JY; Bollaert PE; Megarbane B; Ricard JD; Anguel N; Vicaut E; Adnet F;
    Lancet; 2009 Jul; 374(9686):293-300. PubMed ID: 19573904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
    Payen JF; Dupuis C; Trouve-Buisson T; Vinclair M; Broux C; Bouzat P; Genty C; Monneret D; Faure P; Chabre O; Bosson JL
    Crit Care Med; 2012 Jan; 40(1):29-35. PubMed ID: 21926601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*.
    Chan CM; Mitchell AL; Shorr AF
    Crit Care Med; 2012 Nov; 40(11):2945-53. PubMed ID: 22971586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute adrenal insufficiency after a single dose of etomidate.
    Lundy JB; Slane ML; Frizzi JD
    J Intensive Care Med; 2007; 22(2):111-7. PubMed ID: 17456730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etomidate as an Induction Agent in Sepsis.
    Devlin RJ; Kalil D
    Crit Care Nurs Clin North Am; 2018 Sep; 30(3):e1-e9. PubMed ID: 30286947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study.
    Tekwani KL; Watts HF; Sweis RT; Rzechula KH; Kulstad EB
    Ann Emerg Med; 2010 Nov; 56(5):481-9. PubMed ID: 20828877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database.
    McPhee LC; Badawi O; Fraser GL; Lerwick PA; Riker RR; Zuckerman IH; Franey C; Seder DB
    Crit Care Med; 2013 Mar; 41(3):774-83. PubMed ID: 23318491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should etomidate be used for rapid-sequence intubation induction in critically ill septic patients? Probably not.
    Dean P
    Am J Emerg Med; 2008 Jul; 26(6):728-9; author reply 729-30. PubMed ID: 18606334
    [No Abstract]   [Full Text] [Related]  

  • 14. Can 1 microg of cosyntropin be used to evaluate adrenal insufficiency in critically ill patients?
    Kozyra EF; Wax RS; Burry LD
    Ann Pharmacother; 2005 Apr; 39(4):691-8. PubMed ID: 15741424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of etomidate as an induction agent for rapid sequence intubation in a pediatric emergency department.
    Zuckerbraun NS; Pitetti RD; Herr SM; Roth KR; Gaines BA; King C
    Acad Emerg Med; 2006 Jun; 13(6):602-9. PubMed ID: 16636355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etomidate for critically ill patients. Pro: yes we can use it.
    Ray DC; McKeown DW
    Eur J Anaesthesiol; 2012 Nov; 29(11):506-10. PubMed ID: 22907611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock.
    Walls RM; Murphy MF
    Ann Emerg Med; 2008 Jul; 52(1):13-4. PubMed ID: 18565378
    [No Abstract]   [Full Text] [Related]  

  • 18. Suspected adrenal insufficiency in critically ill burned patients: etomidate-induced or critical illness-related corticosteroid insufficiency?-A review of the literature.
    Mosier MJ; Lasinski AM; Gamelli RL
    J Burn Care Res; 2015; 36(2):272-8. PubMed ID: 25055003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etomidate, sepsis, and adrenal function: not as bad as we thought?
    Kamp R; Kress JP
    Crit Care; 2007; 11(3):145. PubMed ID: 17610749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients.
    Vinclair M; Broux C; Faure P; Brun J; Genty C; Jacquot C; Chabre O; Payen JF
    Intensive Care Med; 2008 Apr; 34(4):714-9. PubMed ID: 18092151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.